View Article

Abstract

Drug repurposing is an emerging strategy used to identify new targets for drugs that are already been in clinical use for a different disease. It is both a cost effective and time saving alternative since the pharmacological, safety and toxicity profiles are already established. The proton pump inhibitor Pantoprazole has shown anticancer activity in few studies done on cancer cell lines and also revealed that it has got a role in the anti-angiogenesis mechanism. To establish the anticancer profile, MTT assay has been done. It showed that Pantoprazole has got cytotoxic activity on cancer cell lines. The preliminary evaluation of cytotoxicity was done on mung beans and evaluated for its sprouting response. The inhibition of germination also revealed the cytotoxic potential of the drug. Chorioallantoic membrane assay was done to evaluate the angiogenic potential of the drug. Pantoprazole disrupted the vascularization in the fertilized egg in a concentration of 50 microgram/ml.

Keywords

Pantoprazole, drug repurposing, angiogenesis, cytotoxicity.

Introduction

Cancer is one of the leading disease which affects the current human population worldwide. It is caused when cells divide in an uncontrollable manner and it damages the body tissues1,2. Even though there are many drugs available in the market, treatment resistance still pose a major threat in the field of oncotherapy. Drug repurposing is the novel strategy which uses an existing drug candidate for a new medical condition other than it was indicated for.  The side effect of a drug can also be utilized for its potential to treat a new disease. Since its safety and efficacy studies were already done for other medical condition, the risks and costs for conducting those studies can be reduced3. The entire drug development process can also be skipped. Based on the phenotypic benefits, drug repurposing can identify new compounds without drawing its mechanism of action4. These drugs directly reach the preclinical testing and it progress directly to Phase II clinical trials5. The risk of failure is minimum with repurposed drugs compared to drugs discovered via traditional approach. From the standard drug discovery process the pharmacokinetic, toxicology and safety data can be extracted. One of the example is Thalidomide, which was once used to treat morning sickness in pregnant women banned due to its terratogenecity is repurposed for the treatment of leprosy and multiple myeloma. In such cases the benefit-to–to-risk ratio has to be considered. Amphotericin B is an antifungal drug now used for leishmaniasis. Tamoxifen is an anticancer drug now used for leishmaniasis therapy. Astemizole is an antihistamine now repurposed for malaria therapy. Minoxidil is anti-hypertensive utilized for treating alopecia. Asprin, an NSAID now also indicated for myocardial infarction. There are many such drugs which are in clinical trials and also available as therapy which implies the significance of drug repurposing. Pantoprazole is a proton pump inhibitor given for the treatment of heartburn, acid reflex and gastro eosophageal reflex disorder. Several studies pointed out the anticancer activity of pantoprazole in in-vitro culture. Weidong Shen et.al., studied the effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho?LRP6 expression in Wnt/?-catenin signaling and found out that pantoprazole has anti-proliferative and pro-apoptotic effects. Zhoulei li et al., studied the action of Pantoprazole and Vitamin C Targeting Tumor Microenvironment Conditions Improves Anticancer Effect in Metastatic Castration-Resistant Prostate Cancer. Zhen-ning L et.al., found out that Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo.

MATERIALS AND METHODS

I. Molecular Docking

Docking is done to find out the binding affinities between the candidate drug and the receptor. It is a preliminary screening tool. Here Pantoprazole is docked with the Vascular endothelial growth factor receptor to find out whether the molecule binds with the protein and thereby understanding whether the drug has got role in the angiogenesis process or not6,7,8.

The software used is GLIDE developed by Schrodinger.

II. MTT Assay

It is the preliminary invitro anticancer test to assess the cytotoxic potential of drugs. Here breast cancer cell lines, Human cervical cancer cell lines are used for the study. Cyclophosphamide is employed as the standard9,10.

1. HeLa cells were grown in the medium at 37?C in an incubator.

2. The cells were counted using a haemocytometer and the number of cells were adjusted to 20,000 cells per ml.

3. In a 96 well plate 200 µl of the cells were seeded in triplicate.

4. Pantoprazole were given in the concentrations of 10,20,30,40,50 µg/ml. The standard drug Cyclophosphamide were also given in these concentrations.

5. Cells are incubated for one day and then washed with PBS.

6. MTT solution was added to each well in the concentration of 20 µl, incubated for four hours. The colour change from yellow to purple is noted.

7. After replacing the solutions from each microtitre well, DMSO is added and the cells were kept at room temperature for half an hour.

8. The optical density was measured using a plate reader at570nm and then percentage viability of the cells was calculated.

III. Evaluation of response of sprouting seeds

The germination of mung beans, Vigna radiate (L.) (Fabaceae) is also a preliminary evalauation method for assessing the cytotoxic potential of the drug11. When the seeds transition from a metabolically inactive quiescent state to the rapid cell division stage it imbibes water. The seeds then shift from G1 to G2 phase that procedes cell division and the growth of the radicle. The weight increase in the seeds is thus indicated as the measure of seedling growth. Hence, the evaluation of germination response of mung beans can be employed as the inexpensive method of screening cytotoxic drugs.

1. Mung beans of uniform weight were taken for the analysis. The weight of each seed is taken and recorded.

2. The seeds were placed in the microtitre plate well and different concentrations of test drug and standard drug solutions were added to it. Distilled water and DMSO control were also set up. It is then kept in an open space for 24 hours.

3. In the concentrations of 10,20,30,40,50 µg/ml, Pantoprazole was given. Cyclophosphamide was also given in the same concentration.

4. After 24 hours and 48 hours the weight of each seeds were noted and then calculate the percentage inhibition of sprouting.

Percentage inhibition = WtD – WtE/ WtD – WtMI

WtD – Wet weight of seed in distilled water

WtE – Wet weight of seed in experimental sample

WtMI – Wet weight of seed in maximum inhibition.

       
            Representative images of the experiment.png
       

Figure 1: Representative images of the experiment ‘Evaluation of response of sprouting seeds’

IV. Chick Chorioallantoic Membrane Assay (CAM Assay)

Angiogenesis is the formation of new blood vessels from the endothelial cell progenitors12,13. Angiogenesis plays a major role in the tumor progression and it is one of the hall marks of cancer. Chorioallantoic membrane is a membrane composed of chorion and allantois and it supplies nutrients to the embryo during its developmental stage14. CAM assay is a good model to study angiogenesis and anti-angiogenesis properties of drugs15,16. The degree of vascularization is studied in this test and compared.

1. 3 day embryonated eggs were collected from nearby poultry farm.

2. The eggs were gently wiped with 70% IPA

3. Air sac was located using a light souce and a cut was made using a forceps. The cut

should be of 1 cm in diameter.

4. Using a syringe carefully remove the albumin.

5. The eggs were covered with a plastic tape and keep in the incubator for 7 days

at 37?C.

6. At the 10th day Pantoprazole was added at the concentration 50?g/?L. The standard

drug was also added at the same concentration. The drug was added using a

micropipette onto a sterilized filter paper disc kept on the CAM.

7. The eggs were covered with plastic tapes and then kept in a incubator for 3

days.

8. At the 13th day eggs were taken from the incubator the shells were removed

and the contents were put in a petridish and photographs were taken.

       
            Representative images of the CAM Assay.png
       

       
            Figure 2.png
       

Figure 2: Representative images of the CAM Assay

RESULTS AND DISCUSSION

  1. Molecular Docking

              
            fig-3.png
       

  Figure 3: Image of Pantoprazole docked with Vascular endothelial growth factor receptor

II. MTT Assay


Table 1: Percentage vaiability of HeLa cells after 24 hours of drug treatment

 

Concentration (?g/mL)

Percentage viability

(Pantoprazole)

Percentage viability

(Cyclophosphamide)

6.25

96.30±0.14

 

86.61±0.12

 

12.5

91.48±0.49

 

75.12±0.20

 

25

85.35±0.17

 

61.09±0.64

 

50

71.64±0.14

 

44.97±0.41

 

100

44.81±0.27

 

22.94±0.26

 


            
            Percentage vaiability of HeLa cells after 24 hours of drug treatment.png
       

    Figure 4: Percentage vaiability of HeLa cells after 24 hours of drug treatment

Dose dependent reduction in cell viability was observed in HeLa cancer cells administered with different concentrations of the Pantoprazole. The maximum cytotoxicity was observed with 100 ?g/mL of the sample (%Viability: 44.81±0.37

%). Thus we can say that Pantoprazole exhibits a dose dependent cytotoxic action and the activity increases with increase in the concentration.

III. Evaluation of response of sprouting seeds

The sprouting response of seeds after treatments with Pantoprazole and Cyclophosphamide were studied in the 24 hour and 48 hour time intervals. The percentage inhibition were calculated and compared with the help of graph. The data indicates that Pantoprazole has inhibitory effect on seed sprouting and the inhibition increases with increase in the dose of drug. Cyclophosphamide being an established cytotoxic drug has good inhibitory property than the test drug. But in higher concentrations, Pantoprazole also shows good percentage inhibition of sprouting response. It indicates the cytotoxic activity of Pantoprazole.

           
            Comparison of percentage inhibition of sprouting after 24 hours of drug treatment.png
       

  Figure 5: Comparison of percentage inhibition of sprouting after 24 hours of drug treatment

          
            Comparison of percentage inhibition of sprouting after 48 hours of drug treatment.png
       

  Figure 6 : Comparison of percentage inhibition of sprouting after 48 hours of drug treatment

IV. Chick Chorioallantoic Membrane Assay (CAM Assay)

Macroscopic observations of Pantoprazole treated egg, Cyclophosphamide treated eggs, untreated control and DMSO control were done. The untreated egg showed normal pattern of blood vessel formation with proper branching pattern. DMSO control has slight breaks in the blood vessels but no significant changes were seen. However, the treatment with 50?g/ml concentration of Pantoprazole produced a significantly visible inhibition in the formation of blood vessels. The branching pattern of blood vessel formation was very poor in the given concentration. The standard drug Cyclophosphamide also show a clear cut inhibition of angiogenesis.

       
            Photographs of eggs after different drug treatments.png
       

Figure7: Photographs of eggs after different drug treatments

  1. Untreated control, 2.  DMSO control, 3. Pantoprazole 50µg/µl,  4. Cyclophosphamide 50µg/µl

CONCLUSION

The proton pump inhibitor drug Pantoprazole is evaluated for its anticancer property. It is an approach to drug repurposing for cancer. The drug has shown significant cytotoxic activity in the MTT Assay and the sprouting seed assay. The docking result revealed that Pantoprazole has good binding efficacy with the Vascular endothelial growth factor receptor which signals the process of angiogenesis. The Chorioallantoic membrane assay showed that the drug has got significant anti-angiogenic potential.

Conflict Of Interest

The authors declare that there are no conflicts of interest.

ACKNOWLEDGEMENT

Dr. Durgesh GV, Research Scholar, NIPER Hyderabad.

REFERENCES

  1. DeVita VT, Lawrence TS, Rosenberg SA. Cancer: Principles and practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer; 2015.
  2. Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell. 2000; 100(1):57–70.
  3. Xia Y, Sun M, Huang H, Jin WL. Drug repurposing for cancer therapy. Signal Transduct Target Ther. 2024 Apr 19;9(1):92.
  4. Kumar S, Roy V. Repurposing Drugs: An Empowering Approach to Drug Discovery and Development. Drug Res (Stuttg). 2023 Nov;73(9):481-490.
  5. Jain P, Jain SK, Jain M. Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies. Curr Mol Med. 2021;21(2):111-132.
  6. Kuntz ID. Structure-based strategies for drug design and discovery. Science. 1992; 257(5073):1078-82.
  7. Verlinde CLMJ. Hol WGJ. Structure based drug design: progress, results and challenges. Structure. 1994; 2(7):577-87.
  8. Lybrand TP. Ligand-protein docking and rational drug design. Current opinion in structural biology. 1995; 5(2):224-28.
  9. Senthilraja P, Kathiresan K. In vitro cytotoxicity MTT assay in Vero, HepG2 and MCF -7 cell lines study of Marine Yeast. Journal of Applied Pharmaceutical Science. 2015Mar;5(3):80–4
  10. Gerlier D, Thomasset N. Use of MTT colorimetric assay to measure cell activation. Journal of immunological methods. 1986; 94(12):57-63.
  11. Kumar VL, Singhal A. Germinating seeds of the mung bean, Vignaradiata (Fabaceae), as a model for the preliminary evaluation of cytotoxic effects of drugs. Biocell. 2008Apr;33(1):19–24.
  12. Ausprunk DH, Knighton DR, Folkman J. Differentiation of vascular endothelium in the chick chorioallantois: A structural and autoradiographic study. Dev Biol. 1974Jun;38(2):237–48.
  13. Ziyad S, Iruela-Arispe ML. Molecular Mechanisms of Tumor Angiogenesis. Genes Cancer. 2011Dec; 2(12):1085–96
  14. Ponce ML, Kleinmann HK. The chick chorioallantoic membrane as an in vivo angiogenesis model. Curr Protoc Cell Biol. 2003May;19(5):1–18.
  15. Ribatti D, Nico B, Vacca A, Roncali L, Burri PH, Djonov V. Chorioallantoic membrane capillary bed: A useful target for studying angiogenesis and anti angiogenesis in vivo. Anat Rec. 2001Dec;264(4):317–24.
  16. Chen Z, Wen Z, Bai X. In vivo Chick ChorioallantoicMembrane(CAM) Angiogenesis Assay. Bio-protocol. 2013Sep;3(18):1-5.

Reference

  1. DeVita VT, Lawrence TS, Rosenberg SA. Cancer: Principles and practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer; 2015.
  2. Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell. 2000; 100(1):57–70.
  3. Xia Y, Sun M, Huang H, Jin WL. Drug repurposing for cancer therapy. Signal Transduct Target Ther. 2024 Apr 19;9(1):92.
  4. Kumar S, Roy V. Repurposing Drugs: An Empowering Approach to Drug Discovery and Development. Drug Res (Stuttg). 2023 Nov;73(9):481-490.
  5. Jain P, Jain SK, Jain M. Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies. Curr Mol Med. 2021;21(2):111-132.
  6. Kuntz ID. Structure-based strategies for drug design and discovery. Science. 1992; 257(5073):1078-82.
  7. Verlinde CLMJ. Hol WGJ. Structure based drug design: progress, results and challenges. Structure. 1994; 2(7):577-87.
  8. Lybrand TP. Ligand-protein docking and rational drug design. Current opinion in structural biology. 1995; 5(2):224-28.
  9. Senthilraja P, Kathiresan K. In vitro cytotoxicity MTT assay in Vero, HepG2 and MCF -7 cell lines study of Marine Yeast. Journal of Applied Pharmaceutical Science. 2015Mar;5(3):80–4
  10. Gerlier D, Thomasset N. Use of MTT colorimetric assay to measure cell activation. Journal of immunological methods. 1986; 94(12):57-63.
  11. Kumar VL, Singhal A. Germinating seeds of the mung bean, Vignaradiata (Fabaceae), as a model for the preliminary evaluation of cytotoxic effects of drugs. Biocell. 2008Apr;33(1):19–24.
  12. Ausprunk DH, Knighton DR, Folkman J. Differentiation of vascular endothelium in the chick chorioallantois: A structural and autoradiographic study. Dev Biol. 1974Jun;38(2):237–48.
  13. Ziyad S, Iruela-Arispe ML. Molecular Mechanisms of Tumor Angiogenesis. Genes Cancer. 2011Dec; 2(12):1085–96
  14. Ponce ML, Kleinmann HK. The chick chorioallantoic membrane as an in vivo angiogenesis model. Curr Protoc Cell Biol. 2003May;19(5):1–18.
  15. Ribatti D, Nico B, Vacca A, Roncali L, Burri PH, Djonov V. Chorioallantoic membrane capillary bed: A useful target for studying angiogenesis and anti angiogenesis in vivo. Anat Rec. 2001Dec;264(4):317–24.
  16. Chen Z, Wen Z, Bai X. In vivo Chick ChorioallantoicMembrane(CAM) Angiogenesis Assay. Bio-protocol. 2013Sep;3(18):1-5.

Photo
Vismaya Babu K. K.
Corresponding author

College of Pharmacy, Kannur Medical College, Anjarakandy

Photo
Sukrutha K. P.
Co-author

College of Pharmacy, Kannur Medical College, Anjarakandy

Photo
Farija R. S.
Co-author

College of Pharmacy, Kannur Medical College, Anjarakandy

Photo
Abitha P. B.
Co-author

College of Pharmacy, Kannur Medical College, Anjarakandy

Photo
Arya P.
Co-author

College of Pharmacy, Kannur Medical College, Anjarakandy

Photo
Amra Raffy K.
Co-author

College of Pharmacy, Kannur Medical College, Anjarakandy

Vismaya Babu K. K.*, Sukrutha K. P., Farija R. S., Abitha P. B., Arya P., Amra Raffy K., Drug Repurposing of Pantoprazole for Its Anticancer Activity Focusing on Its Anti-Angiogenic Potential, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 2, 129-135. https://doi.org/10.5281/zenodo.14792519

More related articles
Decoding Breast Cancer Complexity: Insights Into P...
Arnab Roy, K. Rajeswar Dutt, Ankita Singh, Mahesh Kumar Yadav, An...
Anticancer Activity of Ethanolic Extract of Coleus...
Sandra P., Safa P. K., Femina Arippayil, Arun Prakash K. V., Hiba...
Decoding Breast Cancer Complexity: Insights Into P...
Arnab Roy, K. Rajeswar Dutt, Ankita Singh, Mahesh Kumar Yadav, An...
Decoding Breast Cancer Complexity: Insights Into Pathogenesis And Emerging Treat...
Arnab Roy, K. Rajeswar Dutt, Ankita Singh, Mahesh Kumar Yadav, Anupama Kumari, Anjali Raj, Umaira Sa...
Related Articles
A Review Article on Conversion of Pantoprazole Crystalline Form to Amorphous For...
Akshay Kerkal, Shruti Sonawane, Sandesh Tule, Shweta Patil, Mansi Shinde, ...
Molecular Simulation and Computational Docking Based Synthesis and Screening of ...
Sathish N. K., Sharanagouda, Dhananjay Mathad, V. V. S. Rajendra prasad, Jaishree V. A., Bhagyashree...
Perspectives On Cancer Stem Cells: Implications For Future Therapies...
Nidhi Srivastava, Mukesh Ramola, Nidhi Tayal, ...
Decoding Breast Cancer Complexity: Insights Into Pathogenesis And Emerging Treat...
Arnab Roy, K. Rajeswar Dutt, Ankita Singh, Mahesh Kumar Yadav, Anupama Kumari, Anjali Raj, Umaira Sa...
More related articles
Decoding Breast Cancer Complexity: Insights Into Pathogenesis And Emerging Treat...
Arnab Roy, K. Rajeswar Dutt, Ankita Singh, Mahesh Kumar Yadav, Anupama Kumari, Anjali Raj, Umaira Sa...
Anticancer Activity of Ethanolic Extract of Coleus Amboinicus...
Sandra P., Safa P. K., Femina Arippayil, Arun Prakash K. V., Hiba Musthafa K. P. R., Nandana P., ...
Decoding Breast Cancer Complexity: Insights Into Pathogenesis And Emerging Treat...
Arnab Roy, K. Rajeswar Dutt, Ankita Singh, Mahesh Kumar Yadav, Anupama Kumari, Anjali Raj, Umaira Sa...
Decoding Breast Cancer Complexity: Insights Into Pathogenesis And Emerging Treat...
Arnab Roy, K. Rajeswar Dutt, Ankita Singh, Mahesh Kumar Yadav, Anupama Kumari, Anjali Raj, Umaira Sa...
Anticancer Activity of Ethanolic Extract of Coleus Amboinicus...
Sandra P., Safa P. K., Femina Arippayil, Arun Prakash K. V., Hiba Musthafa K. P. R., Nandana P., ...
Decoding Breast Cancer Complexity: Insights Into Pathogenesis And Emerging Treat...
Arnab Roy, K. Rajeswar Dutt, Ankita Singh, Mahesh Kumar Yadav, Anupama Kumari, Anjali Raj, Umaira Sa...